Suppr超能文献

金黄色葡萄球菌通过 CXCL10 获得对糖肽类抗生素万古霉素的耐药性。

Staphylococcus aureus acquires resistance to glycopeptide antibiotic vancomycin via CXCL10.

机构信息

Department of Urology, The Second Hospital of Jilin University, Changchun 130022, PR China.

Department of Urology, The Second Hospital of Jilin University, Changchun 130022, PR China.

出版信息

Int Immunopharmacol. 2024 May 10;132:111780. doi: 10.1016/j.intimp.2024.111780. Epub 2024 Apr 10.

Abstract

BACKGROUND

Glycopeptide antibiotic vancomycin is a bactericidal antibiotic available for the infection to Staphylococcus aureus (SA), however, SA has a strong adaptive capacity and thereby acquires resistance to vancomycin. This study aims to illuminate the possible molecular mechanism of vancomycin resistance of SA based on the 16S rRNA sequencing data and microarray profiling data.

METHODS

16S rRNA sequencing data of control samples and urinary tract infection samples were retrieved from the EMBL-EBI (European Molecular Biology Laboratory - European Bioinformatics Institute) database. Correlation of gut flora and clinical indicators was evaluated. The possible targets regulated by SA were predicted by microarray profiling and subjected to KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis. CXCL10 gene knockout and overexpression were introduced to evaluate the effect of CXCL10 on the virulence of SA and the resistance to vancomycin. SA strains were co-cultured with urethral epithelial cells in vitro. The presence of SA virulence factors was detected using PCR. Biofilm formation of SA strains was assessed using the microtiter plate method. Furthermore, the antibiotic sensitivity of SA strains was evaluated through vancomycin testing.

RESULTS

Gut flora and its species abundance had significant difference between urinary tract infection and control samples. SA was significantly differentially expressed in urinary tract infection samples. Resistance of SA to vancomycin mainly linked to the D-alanine metabolism pathway. SA may participate in the occurrence of urinary tract infection by upregulating CXCL10. In addition, CXCL10 mainly affected the SA resistance to vancomycin through the TLR signaling pathway. In vitro experimental results further confirmed that the overexpression of CXCL10 in SA increased SA virulence and decreased its susceptibility to vancomycin. In vitro experimental validation demonstrated that the knockout of CXCL10 in urethral epithelial cells enhanced the sensitivity of Staphylococcus aureus (SA) to vancomycin.

CONCLUSION

SA upregulates the expression of CXCL10 in urethral epithelial cells, thereby activating the TLR signaling pathway and promoting resistance to glycopeptide antibiotics in SA.

摘要

背景

糖肽类抗生素万古霉素是一种杀菌抗生素,可用于治疗金黄色葡萄球菌 (SA) 的感染,然而,SA 具有很强的适应性,从而获得对万古霉素的耐药性。本研究旨在基于 16S rRNA 测序数据和微阵列分析数据阐明 SA 对万古霉素耐药的可能分子机制。

方法

从 EMBL-EBI(欧洲分子生物学实验室 - 欧洲生物信息学研究所)数据库中检索对照样本和尿路感染样本的 16S rRNA 测序数据。评估肠道菌群与临床指标的相关性。通过微阵列分析预测 SA 可能受调控的靶点,并进行京都基因与基因组百科全书 (KEGG) 富集分析。引入 CXCL10 基因敲除和过表达,评估 CXCL10 对 SA 毒力和万古霉素耐药性的影响。体外共培养 SA 菌株与尿道上皮细胞,通过 PCR 检测 SA 毒力因子的存在。采用微量滴定板法评估 SA 菌株生物膜形成。此外,通过万古霉素试验评估 SA 菌株的抗生素敏感性。

结果

尿路感染和对照样本的肠道菌群及其物种丰度有显著差异。SA 在尿路感染样本中差异表达显著。SA 对万古霉素的耐药性主要与 D-丙氨酸代谢途径有关。SA 可能通过上调 CXCL10 参与尿路感染的发生。此外,CXCL10 主要通过 TLR 信号通路影响 SA 对万古霉素的耐药性。体外实验结果进一步证实,SA 中 CXCL10 的过表达增加了 SA 的毒力,降低了其对万古霉素的敏感性。体外实验验证表明,尿道上皮细胞中 CXCL10 的敲除增强了 SA 对万古霉素的敏感性。

结论

SA 在上皮细胞中上调 CXCL10 的表达,从而激活 TLR 信号通路,促进 SA 对糖肽类抗生素的耐药性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验